BILL ANALYSIS

HR6199

BULLISH

Medical Nutrition Therapy Act of 2025

HR6199 (Medical Nutrition Therapy Act of 2025) has been assessed with a bullish outlook for investors. This legislation directly affects CVS Health ($CVS) and UnitedHealth Group ($UNH). The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.

bullish

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR6199 expands Medicare MNT coverage to obesity, eating disorders, cancer, HIV/AIDS — a 3-5x increase in addressable Medicare beneficiaries for nutrition therapy.

Bill is early-stage (referred to two committees) with companion Senate bill; no CBO score or committee markup yet.

UNH and CVS have the integrated care infrastructure to capture MNT patient volume through their clinics and Medicare Advantage plans.

No specific funding amount is authorized; increased coverage would be paid through existing Medicare Part B framework.

30-day price trends for UNH (+35.54%) and CVS (+15.98%) are driven by broader earnings momentum, not this bill.

How HR6199 Affects the Market

UNH at $366.75 and CVS at $83.30 have already rallied significantly in the past 30 days. HR6199's expansion of MNT represents a modest additional tailwind if passed, but neither stock currently prices in any probability of this bill. Near-term focus should be on committee markups and CBO scoring, which would be the first material catalysts. For retail investors, this is a low-probability/high-impact legislative event that adds optionality to existing positions in integrated care plays but does not justify a standalone bet.

Bill Details

Metric	Value
Bill Number	HR6199
Market Sentiment	bullish
Event Date	November 20, 2025
Affected Sectors	Healthcare
Affected Stocks	CVS Health ($CVS), UnitedHealth Group ($UNH)
Source	View on Congress.gov →

Summary

Bipartisan bill to expand Medicare MNT coverage to obesity, cancer, eating disorders, and HIV/AIDS — currently in early House committee stage with 17 cosponsors and a companion Senate bill. Expands the addressable market for nutrition therapy services within Medicare by 3-5x. UNH and CVS stand to benefit from increased patient volume in their integrated care and pharmacy networks, though passage is not guaranteed in 2026.

Full AI Market Analysis

The Medical Nutrition Therapy Act of 2025 (HR6199) was introduced in the House on November 20, 2025, by Rep. Kelly (D-IL) with 17 cosponsors. It has been referred to the Energy and Commerce and Ways and Means committees. A companion bill (S3934) was introduced in the Senate on March 25, 2026. The bill is in its early stages and faces a competitive legislative calendar in the 119th Congress. The money trail: The bill does not authorize or appropriate any specific dollar amount. It amends Section 1861 of the Social Security Act to expand the definition of covered medical nutrition therapy services under Medicare Part B. Any spending increase would be scored by CBO as increased Medicare outlays, offset by potential reductions in hospitalizations and disease progression costs that the bill cites in its findings. Structural winners: Integrated healthcare payers and providers with in-house nutrition/dietary service capabilities — specifically UNH (Optum clinics and UnitedHealthcare Medicare Advantage) and CVS (MinuteClinic, HealthHUB, Aetna MA). These companies have the direct care delivery infrastructure to capture the new MNT referrals. Pure-play nutrition services are primarily private-practice dietitians (not publicly traded) and thus not captured. Real market data analysis: Over the past 30 days, UNH has surged +35.54% from ~$270 to $366.75, and CVS has gained +15.98% from ~$72 to $83.30, both outpacing the broader market. These moves predate any specific progress on this bill — they reflect sector-level earnings momentum. The bill's early stage means current stock prices likely do not price in any MNT expansion premium. Timeline: The bill must pass the House Energy and Commerce and Ways and Means committees, then the full House, then be reconciled with S3934, and be signed into law. With a presidential election year (2026 midterms), the window for major healthcare legislation is narrow. Passage probability is low in 2026.